-

Cutera to Announce First Quarter Results on May 9, 2024

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024.

The Company’s management will host a conference call to discuss these results and related matters at 1:30 p.m. PT (4:30 p.m. ET) that same day.

Participants can register for the conference call at the following registration link. Upon registering, a calendar booking will be provided by email including the dial-in details and a unique PIN to access the call. Using this process will by-pass the operator and avoid the call queue. Registration will remain open until the end of the live conference call.

If participants prefer to dial in and speak with an operator, dial Canada/USA Toll Free: 1-844-763-8274 or +1-647-484-8814. It is recommended that you call in 10 minutes prior to the scheduled start time if you are using one of these operator-assisted phone numbers.

The call will also be webcast and can be accessed from the Investor Relations section of Cutera’s website at http://www.cutera.com/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About Cutera, Inc.

Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera has strived to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call +1-415-657-5500 or 1-888-4CUTERA or visit www.cutera.com.

Contacts

Cutera, Inc.
Greg Barker
VP, Corporate FP&A and Investor Relations
415-657-5500
IR@cutera.com

Cutera, Inc.

NASDAQ:CUTR
Details
Headquarters: Brisbane, CA
CEO: Ron Louks
Employees: 450
Organization: PRI

Release Versions

Contacts

Cutera, Inc.
Greg Barker
VP, Corporate FP&A and Investor Relations
415-657-5500
IR@cutera.com

More News From Cutera, Inc.

Cutera® Appoints Chris House as Chief Technology Officer and Charles Hunt as Vice President of Design & Experience, Reinforcing Commitment to Innovation

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., a leading provider of aesthetic and dermatological solutions, announces today the appointments of Chris House as Chief Technology Officer and Charles Hunt as Vice President of Design and Experience. These strategic appointments underscore Cutera’s commitment to next-generation solutions and customer-centered product development. As Chief Technology Officer, Chris House will lead Cutera’s global technology and product development strategy, focusin...

Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure

BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...

Cutera Announces Voluntarily Delisting from Nasdaq

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (“Cutera” or the “Company”) (Nasdaq: CUTR) today announced that it has formally notified The Nasdaq Stock Market LLC (“Nasdaq”) of its intent to voluntarily delist its common stock from the Nasdaq Global Select Market. Cutera expects to file a Form 25 with the Securities and Exchange Commission (the "SEC") relating to the voluntary delisting of its common stock on or about March 20, 2025. The Company expects the delisting of the common stock to be...
Back to Newsroom